Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Vestrheim DF"'
Autor:
Hanquet G, Krizova P, Dalby T, Ladhani SN, Nuorti JP, Danis K, Mereckiene J, Knol MJ, Winje BA, Ciruela P, de Miguel S, Portillo ME, MacDonald L, Morfeldt E, Kozakova J, Valentiner-Branth P, Fry NK, Rinta-Kokko H, Varon E, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Sanz JC, Castilla J, Smith A, Henriques-Normark B, Colzani E, Pastore-Celentano L, Savulescu C, SpIDnet group1
Publikováno v:
EMERGING INFECTIOUS DISEASES
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in 10 countries in Europe. IPD incidence declined during 2011-2014 but incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::540e857fdb555ccf07a4a3b204cec6a0
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20494
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20494
Autor:
Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela Navas P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B, Celentano LP, Hanquet G, SpIDnet group
Publikováno v:
LANCET RESPIRATORY MEDICINE
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
BACKGROUND: The Streptococcus pneumoniae Invasive Disease network (SpIDnet) actively monitors populations in nine sites in seven European countries for invasive pneumococcal disease. Five sites use 13-valent pneumococcal conjugate vaccine (PCV13) alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1d887d86f9e3b65f14e88ee329d69d38
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11077
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=11077
Autor:
Veneti L; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Lovisenberggata 8, Oslo, 0456, Norway. Lamprini.Veneti@fhi.no., Robberstad B; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Steens A; Department of Infection Control and Vaccine, Norwegian Institute of Public Health, Oslo, Norway., Forland F; Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Lovisenberggata 8, Oslo, 0456, Norway., Winje BA; Department of Infection Control and Vaccine, Norwegian Institute of Public Health, Oslo, Norway., Vestrheim DF; Department of Infection Control and Vaccine, Norwegian Institute of Public Health, Oslo, Norway., Jarvis CI; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Gimma A; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Edmunds WJ; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Van Zandvoort K; Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., de Blasio BF; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.; Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Publikováno v:
BMC public health [BMC Public Health] 2024 May 29; Vol. 24 (1), pp. 1438. Date of Electronic Publication: 2024 May 29.
Autor:
Van Boetzelaer E; Department of Zoonotic, Food and Waterborne Infections, Norwegian Institute of Public Health, Oslo, Norway.; ECDC Fellowship Program, Field Epidemiology Path (EPIET), Stockholm, Sweden., Daae A; Department of Zoonotic, Food and Waterborne Infections, Norwegian Institute of Public Health, Oslo, Norway., Winje BA; Department of Zoonotic, Food and Waterborne Infections, Norwegian Institute of Public Health, Oslo, Norway., Vestrheim DF; Department of Zoonotic, Food and Waterborne Infections, Norwegian Institute of Public Health, Oslo, Norway., Steens A; Department of Zoonotic, Food and Waterborne Infections, Norwegian Institute of Public Health, Oslo, Norway., Stefanoff P; Department of Zoonotic, Food and Waterborne Infections, Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1976035. Date of Electronic Publication: 2021 Oct 29.
Autor:
van Boetzelaer E; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.; ECDC Fellowship Program, Field Epidemiology Path (EPIET), Stockholm, Sweden., Daae A; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway., Winje BA; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway., Vestrheim DF; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway., Steens A; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway., Stefanoff P; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1971921. Date of Electronic Publication: 2021 Oct 06.
Autor:
Sherwood E; Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: emmasherwood@nhs.net., Vergnano S; Paediatric Infectious Diseases, Bristol Royal Hospital for Children, University Hospitals Bristol NHS, Bristol, UK., Kakuchi I; Paediatric Infectious Diseases, Bristol Royal Hospital for Children, University Hospitals Bristol NHS, Bristol, UK., Bruce MG; Centers for Disease Control and Prevention, Arctic Investigations Program, Anchorage, Alaska, USA., Chaurasia S; Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India., David S; British Columbia Centre for Disease Control, University of British Columbia, BC, Canada., Dramowski A; Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Georges S; Infectious Diseases Department, Santé Publique France, French National Public Health Agency, St Maurice, France., Guy R; National Infection Service, UK Health Security Agency, London, UK., Lamagni T; National Infection Service, UK Health Security Agency, London, UK., Levy-Bruhl D; Infectious Diseases Department, Santé Publique France, French National Public Health Agency, St Maurice, France., Lyytikäinen O; National Institute for Health and Welfare, Department of Health Security, Infectious Disease Control and Vaccinations Unit, Helsinki, Finland., Naus M; British Columbia Centre for Disease Control, University of British Columbia, BC, Canada., Okaro JO; Centers for Disease Control and Prevention, Atlanta, GA, USA., Oppegaard O; Department of Medicine, Haukeland University Hospital, Bergen, Norway., Vestrheim DF; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway., Zulz T; Centers for Disease Control and Prevention, Arctic Investigations Program, Anchorage, Alaska, USA., Steer AC; Murdoch Children's Research Institute, Melbourne, VIC, Australia., Van Beneden CA; Centers for Disease Control and Prevention, Atlanta, GA, USA., Seale AC; Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Jul; Vol. 22 (7), pp. 1076-1088. Date of Electronic Publication: 2022 Apr 04.
Autor:
Savulescu C; Epiconcept, Paris, France., Krizova P; National Institute of Public Health, Prague, Czech Republic., Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark., Ladhani S; Public Health England, London, United Kingdom., Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland., Levy C; ACTIV, Créteil, France., Mereckiene J; Health Protection Surveillance Centre Dublin, Ireland., Knol M; National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Winje BA; Norwegian Institute of Public Health, Oslo, Norway., Ciruela P; Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., de Miguel S; General Directorate of Public Health Madrid, Spain., Guevara M; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., MacDonald L; Public Health Scotland, Glasgow, Scotland, UK., Kozakova J; National Institute of Public Health, Prague, Czech Republic., Slotved HC; Statens Serum Institut, Copenhagen, Denmark., Fry NK; Public Health England, London, United Kingdom., Pekka Nuorti J; National Institute for Health and Welfare, Helsinki, Finland; Tampere University, Tampere, Finland., Danis K; Santé publique France, the National Public Health Institute, Saint-Maurice, France., Corcoran M; Temple Street Children's University Hospital, Irish Pneumococcal Reference Laboratory, Dublin, Ireland., van der Ende A; Academic Medical Centre, National Reference Laboratory for Bacterial Meningitis, Amsterdam, the Netherlands., Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway., Munoz-Almagro C; Hospital Sant Joan de Déu, and International University of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., Sanz JC; General Directorate of Public Health Madrid, Spain., Castilla J; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., Smith A; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary & MVLS, University of Glasgow, Glasgow, Scotland, UK., Colzani E; European Centre for Disease Prevention and Control, Stockholm, Sweden., Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden., Hanquet G; Epiconcept, Paris, France; Antwerp university, Antwerp, Belgium. Electronic address: ghanquet@skynet.be.
Publikováno v:
Vaccine [Vaccine] 2022 Jun 23; Vol. 40 (29), pp. 3963-3974. Date of Electronic Publication: 2022 May 28.
Autor:
Brandal LT; Norwegian Institute of Public Health, Oslo, Norway. lin.thorstensen.brandal@fhi.no.; European Program for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. lin.thorstensen.brandal@fhi.no., Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway., Bruvik T; Norwegian Institute of Public Health, Oslo, Norway., Roness RB; Norwegian Institute of Public Health, Oslo, Norway., Bjørnstad ML; Norwegian Institute of Public Health, Oslo, Norway., Greve-Isdahl M; Norwegian Institute of Public Health, Oslo, Norway., Steens A; Norwegian Institute of Public Health, Oslo, Norway., Brynildsrud OB; Norwegian Institute of Public Health, Oslo, Norway.; Norwegian University of Life Sciences, Ås, Norway.
Publikováno v:
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2022 Jun; Vol. 41 (6), pp. 913-924. Date of Electronic Publication: 2022 May 11.
Autor:
Lefrancq N; Insitut Pasteur, Université Paris Cité, Mathematical Modelling of Infectious Diseases Unit, UMR2000, CNRS, 75015 Paris, France.; Department of Genetics, University of Cambridge, Cambridge CB2 3EH, UK., Bouchez V; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, 75724 Paris, France.; National Reference Center for Whooping Cough and Other Bordetella Infections, 75724 Paris, France., Fernandes N; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, 75724 Paris, France., Barkoff AM; University of Turku UTU, Institute of Biomedicine, Research Center for Infections and Immunity, FI-20520 Turku, Finland., Bosch T; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, Netherlands., Dalby T; Statens Serum Institut, Bacteria, Parasites and Fungi/Infectious Disease Preparedness, 2300 Copenhagen, Denmark., Åkerlund T; The Public Health Agency of Sweden, Unit for Laboratory Surveillance of Bacterial Pathogens, SE-171 82 Solna, Sweden., Darenberg J; The Public Health Agency of Sweden, Unit for Laboratory Surveillance of Bacterial Pathogens, SE-171 82 Solna, Sweden., Fabianova K; National Institute of Public Health, Department of Infectious Diseases Epidemiology, CZ-10000 Prague, Czech Republic., Vestrheim DF; Norwegian Institute of Public Health, Department of Infectious Disease Control and Vaccine, N-0213 Oslo, Norway., Fry NK; Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England-National Infection Service, London NW9 5EQ, UK.; Immunisation and Countermeasures Division, Public Health England-National Infection Service, London NW9 5EQ, UK., González-López JJ; University Hospital Vall d'Hebron, Microbiology Department, 08035 Barcelona, Spain.; Universitat Autònoma de Barcelona, Department of Genetics and Microbiology, 08193 Barcelona, Spain., Gullsby K; Centre for Research and Development, Uppsala University/Region Gävleborg, 80187 Gävle, Sweden., Habington A; Molecular Microbiology Laboratory, Children's Health Ireland, Crumlin, D12 N512 Dublin, Ireland., He Q; University of Turku UTU, Institute of Biomedicine, Research Center for Infections and Immunity, FI-20520 Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, FI-20520 Turku, Finland., Litt D; Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England-National Infection Service, London NW9 5EQ, UK., Martini H; Department of Microbiology, National Reference Centre for Bordetella pertussis, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), B-1090 Brussels, Belgium., Piérard D; Department of Microbiology, National Reference Centre for Bordetella pertussis, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), B-1090 Brussels, Belgium., Stefanelli P; Department of Infectious Diseases, Istituto Superiore di Sanità, IT-00161 Rome, Italy., Stegger M; Statens Serum Institut, Bacteria, Parasites and Fungi/Infectious Disease Preparedness, 2300 Copenhagen, Denmark., Zavadilova J; National Institute of Public Health, National Reference Laboratory for Pertussis and Diphtheria, 100 00 Prague, Czech Republic., Armatys N; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, 75724 Paris, France.; National Reference Center for Whooping Cough and Other Bordetella Infections, 75724 Paris, France., Landier A; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, 75724 Paris, France.; National Reference Center for Whooping Cough and Other Bordetella Infections, 75724 Paris, France., Guillot S; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, 75724 Paris, France.; National Reference Center for Whooping Cough and Other Bordetella Infections, 75724 Paris, France., Hong SL; Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium., Lemey P; Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium., Parkhill J; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK., Toubiana J; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, 75724 Paris, France.; National Reference Center for Whooping Cough and Other Bordetella Infections, 75724 Paris, France.; Université Paris Cité, Department of General Paediatrics and Paediatric Infectious Diseases, Necker-Enfants Malades Hospital, APHP, 75015 Paris, France., Cauchemez S; Insitut Pasteur, Université Paris Cité, Mathematical Modelling of Infectious Diseases Unit, UMR2000, CNRS, 75015 Paris, France., Salje H; Insitut Pasteur, Université Paris Cité, Mathematical Modelling of Infectious Diseases Unit, UMR2000, CNRS, 75015 Paris, France.; Department of Genetics, University of Cambridge, Cambridge CB2 3EH, UK., Brisse S; Institut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, 75724 Paris, France.; National Reference Center for Whooping Cough and Other Bordetella Infections, 75724 Paris, France.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Apr 27; Vol. 14 (642), pp. eabn3253. Date of Electronic Publication: 2022 Apr 27.
Autor:
Oxman AD; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway. oxman@online.no., Fretheim A; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway.; Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway., Lewin S; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway.; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa., Flottorp S; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway.; Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway., Glenton C; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway., Helleve A; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway.; Centre for Evaluation of Public Health Measures, Norwegian Institute of Public Health, Oslo, Norway., Vestrheim DF; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway., Iversen BG; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway., Rosenbaum SE; Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Skøyen, Postboks 222, 0213, Oslo, Norway.
Publikováno v:
Health research policy and systems [Health Res Policy Syst] 2022 Mar 05; Vol. 20 (1), pp. 28. Date of Electronic Publication: 2022 Mar 05.